Rampak, Ameer B.

HRN: 27-64-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/21/2025
08/26/2025
ORAL
4ml
Q12hours
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines